Table 2.
Initial characteristics of PE groups without and with cardiac involvement
| PE without cardiac involvement, n=231 | PE with cardiac involvement, n=186 | P-value | |
| Sex F/M, n (%) | 113 (48.9) | 108 (58.1) | 0.074 |
| Age, years (mean±SD) | 61±17.2 | 63±15.5 | 0.12 |
| Arterial hypertension, n (%) | 90 (39) | 89 (48) | 0.068 |
| Obesity, n (%) | 43 (19) | 31 (17) | 0.622 |
| Dyslipidaemia, n (%) | 53 (23) | 56 (30) | 0.09 |
| Diabetes, n (%) | 21 (9) | 34 (18) | 0.006 |
| Smoking, n (%) | 72 (31) | 38 (20) | 0.012 |
| History of stroke, n (%) | 10 (4) | 16 (8.6) | 0.073 |
| Inflammatory disease, n (%) | 17 (7) | 16 (8.6) | 0.187 |
| Psychiatric pathology, n (%) | 45 (20) | 38 (20) | 0.809 |
| Family history of VTE | 15 (6.5) | 12 (6.5) | 0.986 |
| Provoked, n (%) | 112 (49) | 100 (54) | 0.284 |
| Associated DVT, n (%) | 90 (39) | 96 (52) | 0.01 |
| Length of hospital stay, days (mean±SD) | 4.7±3 | 7.3±4 | 0.004 |
| Tp (ng/L) | 17(17–17) | 298 (206–376) | 0.0001 |
| BNP (pg/L) | 30(25-34) | 293 (241–327) | 0.0001 |
| RV/LV | 0.62±0.07 | 0.96±0.05 | 0.01 |
| Duration in months of initial anticoagulation | 5.18±2.4 | 5.2±2.3 | 0.417 |
BNP, brain natriuretic peptide; DVT, deep vein thrombosis; RV/LV, right-to-left ventricular end-diastolic diameter ratio >0;.9 in the apical four-chamber view.Tp, troponin; VTE, venous thromboembolism.